Skip to main content
. 2002 Jan;70(1):79–85. doi: 10.1128/IAI.70.1.79-85.2002

FIG. 3.

FIG. 3.

(A) Relative representations of HLA-DR alleles in subjects tested for CD4+ T-cell proliferative responses. (B) Percentages of subjects responding to the different Mce2-derived peptides. (C) Correlation between percentages of proliferative responses obtained in the CD4+ T-cell stimulation assay and mean IC50s detected in the HLA-DR-binding assay with peptides 1, 2, 4, and 5.